Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBSERVATIONAL COHORT STUDY EVALUATING REAL-WORLD ABRYSVO VACCINE EFFECTIVENESS AND IMPACT AGAINST MEDICALLY-ATTENDED RSV-RELATED AND ALL-CAUSE OUTCOMES AMONG INFANTS BORN TO INDIVIDUALS VACCINATED DURING PREGNANCY

NCT07249320 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07249320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07249320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBSERVATIONAL COHORT STUDY EVALUATING REAL-WORLD ABRYSVO VACCINE EFFECTIVENESS AND IMPACT AGAINST MEDICALLY-ATTENDED RSV-RELATED AND ALL-CAUSE OUTCOMES AMONG INFANTS BORN TO INDIVIDUALS VACCINATED DURING PREGNANCY
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2025
Completion date
September 30, 2027
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus (rsv)